Literature DB >> 17499153

Role of Zn2+ in epigallocatechin gallate affecting the growth of PC-3 cells.

Xun Chen1, Haining Yu, Shengrong Shen, Junjie Yin.   

Abstract

Green tea has chemo-preventive effects to human carcinoma including prostate cancer. Epigallocatechin gallate (EGCG) is the major active component in green tea. Zn(2+) is indispensable to our health, and plays an important role in the normal function and pathology of the prostate gland, and might be a good marker for diagnosing prostate cancer. Effects of Zn(2+), EGCG and their interactions on the growth of androgen-insensitive prostate cancer cell (PC-3) were investigated in the present paper. The results show that Zn(2+) and EGCG inhibited the growth of PC-3 cells in a time- and dose-dependent manner, but effects of interactions of EGCG with Zn(2+) were extremely dependent on their concentrations and added orders. Inhibitory effects of Zn(2+) were significantly decreased in the presence of EGCG on PC-3 cell growth. Therefore, we hypothesize that complexation of EGCG with Zn(2+) might be responsible for the observed decrease of the bioactivities of Zn(2+) against PC-3 cells.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17499153     DOI: 10.1016/j.jtemb.2006.12.007

Source DB:  PubMed          Journal:  J Trace Elem Med Biol        ISSN: 0946-672X            Impact factor:   3.849


  3 in total

Review 1.  New insights into the mechanisms of green tea catechins in the chemoprevention of prostate cancer.

Authors:  Shahnjayla K Connors; Ganna Chornokur; Nagi B Kumar
Journal:  Nutr Cancer       Date:  2011-11-18       Impact factor: 2.900

2.  Epigallocatechin-3-gallate affects the growth of LNCaP cells via membrane fluidity and distribution of cellular zinc.

Authors:  Jun-guo Yang; Hai-ning Yu; Shi-li Sun; Lan-cui Zhang; Guo-qing He; Undurti N Das; Hui Ruan; Sheng-rong Shen
Journal:  J Zhejiang Univ Sci B       Date:  2009-06       Impact factor: 3.066

3.  Epigallocatechin-3-gallate and zinc provide anti-apoptotic protection against hypoxia/reoxygenation injury in H9c2 rat cardiac myoblast cells.

Authors:  Xing Zeng; Xuerui Tan
Journal:  Mol Med Rep       Date:  2015-04-08       Impact factor: 2.952

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.